Search Results

In this protected environment, pharmacokinetics can decouple from plasma clearance. When a drug rebounds after dissociating—something only possible in a diffusion-limited space—it can maintain New Tools for Getting Drugs Inside Cells All of this hinges on a simple question: can your compound get And while orthosteric ligands may never reach them, properly designed intracellular drugs can. Only in Terry’s Corner   Why Terry’s Corner In a world where GPCR science moves faster than most teams can

A well-behaved molecule in a dish can fail spectacularly in vivo, leaving teams with years of sunk costs Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Allosteric antibodies can mirror or exceed small molecule complexity. Early cross-screening can flag biased phenotypes long before animal studies. Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.

You can have the most brilliant minds and cutting-edge assays, but if your science isn't continuously integrated with your GPCR operational strategy and investment goals, even the most promising program can I understand that embracing a systematic approach can feel daunting, especially with the pressure to Brainstorm Officer, Attila Foris , is building a system so transparent that anyone joining the company can the momentum your GPCR program needs. 👉 https://calendly.com/drgpcr/yamina-corner Or explore how we can

A GPCR program can have world-class science, top-tier talent, and millions in funding — and still fail Every two-week delay in a DMTA cycle can burn through hundreds of thousands in salaries and overhead. discovery data management  pipeline, teams waste hours cleaning, reconciling, and integrating before they can the momentum your GPCR program needs. 👉 https://calendly.com/drgpcr/yamina-corner Or explore how we can

.” — Tom Sakmar A Use Case for Every Angle Beyond RAMPs, this platform can study: Scaffold protein interactions Kotliar sums it up best: “We went from one receptor to many… and now, from many, we can go back to one

receptor environments  amplifies target occupancy, even post-clearance ✅ Insight into why half-life can Drugs with poor pharmacokinetics can outperform flashier compounds by exploiting kinetic environments Why Half-Life Can Lie to You Most teams use systemic half-life as a proxy for action. Only in Terry’s Corner Why Terry’s Corner In a world where drug discovery is evolving faster than most can

No more guesswork, only decisions you can trust. Scatter can masquerade as signal. Subtle shifts vanish in noise. Instead of relying on debate—or worse, intuition—you can calculate an F-value that objectively shows It gives you the power to compare slopes and elevations statistically—so you can confirm whether your lectures  that sharpen the tools you actually use in discovery A growing on-demand library  of lessons you can

In early-stage drug discovery, one miscalculated liability can bring an otherwise promising scaffold Highly selective filters can streamline resource allocation Early elimination of unsafe scaffolds prevents Metabolites and Irreversible Damage Formation of reactive metabolites that alkylate proteins or nucleic acids can Kenakin details how discovery teams can leverage atypical conditions to elucidate liabilities and satisfy

Schild analysis remains one of the few conceptual anchors that can tell us when “simple” truly is simple—and No reduction  in the maximal response (the receptor can still be fully activated). Curvature  can signify heterogeneous receptors  or mixed response mechanisms. It can uncover what’s really  happening inside a complex system. Schild analysis remains the simplest, most revealing conversation we can have with biology.

This technique can acquire three-dimensional image stacks, facilitating the reconstruction of GPCR distribution This enzyme has been modified so a small molecule will covalently bind to it, which can in turn be attached They can be combined with other ligands and are very interesting in TR-FRET (Time-Resolved Förster Energy It can even study the GPCR distribution within endocytic vesicles and across subcellular compartments

In the realm of molecular research, precise interpretation is crucial; a misread curve can lead to lost exposes why traditional displacement logic breaks down in allosteric systems, and how overlooking this can Avoid costly blind spots:  Discover how G protein stoichiometry can dictate whether your assay informs—or Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not

donors used in this technique have longer half-lives  than other fluorophores (between 300μs–1 ms) and can Quite often, there is a need to amplify the signal  strength to detect them, which can be achieved by They can be combined with second generation acceptors like d2, as well as brighter donors, further increasing It can also be combined with  multiplexing . By using donor-acceptor pairs with different emission spectra that don’t overlap, researchers can design

These changes can alter how the receptor talks to G proteins, arrestins, or other receptors. this lecture is how cryptic binding pockets —sites that only exist briefly in certain receptor states—can candidates Underestimation of in vivo potency Kenakin explains why recognizing this phenomenon early can Outdated models can mislead your team, waste your resources, and cost your pipeline months of progress

Welcome back GPCR lovers, In pharmacology, the wrong interpretation of antagonist behavior can derail Solve the problem of misinterpreting your data by understanding how slow-offset kinetics can mimic classical Avoid the professional threat of flawed data interpretations that can lead to costly dead ends and missed Breakthroughs, Not Breakdowns In the fast-paced world of GPCR drug discovery, the "go fast" mindset can Our content is meticulously vetted and organized to provide clarity and actionable insights that you can

These sites act as molecular switches that can modulate receptor activity, providing an untapped opportunity Allosteric ligands can be classified as positive allosteric modulators (PAMs), which increase the receptor Alternatively, they can function as neutral allosteric ligands (NALs), binding to a receptor's allosteric Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence Allosteric agonists binding to intracellular sites can also promote G-protein signaling.

Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing Right) Early discovery often serves you overlapping curves and noisy baselines; different mechanisms can Get an answer you can defend. Corner Today ➤ Celtarys Research – Confocal Imaging That Preserves GPCR Function Confocal imaging can Physiological relevance:  Fluorescent ligands can retain receptor integrity—critical when signaling readouts

conformations, and the binding of a ligand, as well as interactions with signaling molecules like G proteins, can Natural and synthetic ligands can be categorized into four distinct efficacy classes: 1) full agonists produce the maximal response and can differ in intrinsic efficacy; 2) partial agonists are incapable neutral antagonists have null intrinsic efficacy, thus not affecting receptor signaling activity, and can Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence

With street-level contamination rising faster than medicine can adapt, Catherine’s work shows why overdose Why Oxygen Monitors Can Miss the Danger Perhaps the most unsettling part of Catherine’s work is the disconnect doesn’t fail in a single, predictable way—it collapses through overlapping pathways that no single drug can And the illicit supply is moving faster than clinical medicine can adjust. The question now is whether science and public health can keep up.”

Even minor adjustments can compromise photophysical properties. The outcome is not just a probe; it’s a tool scientists can trust. Whether in industry or academia, whether overexpressing or not, you can adapt the assay to your system Build or adopt assays that can evolve with your questions—like pHSense.” What’s Next?

Here you can find the full program . Figure 1. UIC Student Center East. you forget the importance GPCRs holds in drug development as a whole, and how each and every finding can Now back in Europe, all she can think about is next year’s date, in Dublin, where she is sure she will

achieve this, the work of Heydenreich et al. (2023) will be analysed to demonstrate how mutagenesis can By identifying key β2AR residues that influence efficacy and potency, pharmaceutical researchers can For example, orthosteric drug design —in which drugs bind to the receptor’s primary active site—can now Alternatively, allosteric modulators , which bind to sites outside the traditional ligand-binding pocket, can Understanding the evolutionary conservation of these residues can lead to the development of drugs that

faster, and stay ahead in GPCR drug discovery with evidence-based insights—no hype, just strategies you can Breakthroughs this week: New work clarifies how active-state GPCR conformations can support coupling Available in four formats, it turns a notoriously tricky measurement into something discovery teams can pharmacology—showing how persistence, precision, and the courage to take on “impossible” chemistry can B y integrating them into GPCR workflows, discovery teams can accelerate identification, characterization

Redefining Opioid Pharmacology Ben and his colleagues discovered that PAMs can dramatically increase His work highlights how foundational GPCR science can drive therapeutic innovation.

“ A substitution of one amino acid by another in a protein can have effects ranging from negligible to While these structural techniques offer significant advantages in drug discovery, no single method can Furthermore, data on the role of specific residues within receptors can provide valuable insights for Through either random or targeted (site-directed) approaches, mutagenesis can provide a comprehensive In summary, mutagenesis can be a critical tool in drug discovery, particularly for studying GPCRs.

Redundancy can be exemplified by the tumor infiltration of Treg cells which can be driven directly by This redundancy can be seen as problematic in drug discovery as blocking a single receptor might not the chemokine-receptor system, different chemokines are able to activate different pathways, which can Signaling bias can be seen as complex as advantageous since selectively inhibiting certain signaling pathways while sparing others, can prevent some of the negative off-target effects.

assays, signaling assays, cell imaging, protein structure determination, and omics applications, which can Classification: AI models can be used to distinguish GPCRs from non-GPCRs, and to classify GPCRs into Mutations: ML methods can determine stabilising mutations that enable structure determination and can Virtual screening: molecular docking and virtual screening can efficiently analyze large databases of Predicting GPCR properties: AI models can predict various properties of GPCRs, such as ligand binding

For complex GPCR systems, this boundary is a strategic advantage: NAMs can only shift an agonist curve Kenakin  showed how the same agonist can behave as near-full, partial, or even silent depending on receptor This is why experts never classify ligands from a single system: The same molecule can occupy different Kenakin  stressed that low-alpha NAMs can resemble competitive antagonists unless deeper kinetic or concentration-range Extremely strong binders can fail in structured tissues because they saturate the periphery and never

“…now you have a plethora of 400 models that you can start with molecular dynamics, docking, virtual iteratively refining the models with docking and mutagenesis data, they developed predictive pipelines that can

. 👉 How long can we operate if fundraising takes longer than expected? Which decisions can we still reverse, and which ones are already locked in? creates the illusion of control 👉 Many biotech founders  believe they are in control because they can They manage cash flow, but they do not actively track which strategic decisions can still be changed In reality, this is the last window where control can still be regained.

Yet one well-timed question can unlock clarity, accelerate a stalled project, or even spark a collaboration s a masterclass in asking better questions in science, not as a skill you’re born with, but one you can I’m running into a problem and I know you work on something similar — can I pick your brain for one minute